Results 11 to 20 of about 4,480,053 (377)
An update on treatment of penile cancer
Therapeutic Advances in Medical Oncology, 2022 Penile cancer is a rare malignancy, particularly in industrialized nations. In the United States, rates are approximately less than 1 per 100,000 men per year with just over 2000 new cases per year. However, there is significantly increased prevalence in
J. Chadha +2 more
semanticscholar +4 more sources
Patients’ Experiences of penile Cancer [PDF]
European Urology, 2011 Penile cancer is a rare but destructive disease in Western populations. In the United Kingdom, penile cancer accounts for
Branney, P, Eardley, I, Witty, K
core +5 more sources
Chemotherapy in penile cancer [PDF]
Therapeutic Advances in Urology, 2012 Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. While this squamous cell cancer responds to chemotherapy, successful treatment of lymphatic metastases can only be achieved with aggressive surgical ...
Oliver W. Hakenberg, Chris Protzel
doaj +3 more sources
Advances in molecular basis of response to immunotherapy for penile cancer: better screening of responders [PDF]
Frontiers in OncologyPenile cancer is a rare malignant tumor of the male urinary system. The treatment benefit of standard first-line chemotherapy is not ideal for patients with locally advanced or metastatic lymph nodes.
Da-Ming Xu +6 more
doaj +2 more sources
Global research trends in penile cancer: Bibliometric and visualized analysis
Frontiers in Oncology, 2023 BackgroundPenile cancer is a malignant tumor of the genitourinary system that mostly occurs in middle-aged and elderly men aged 50–70 years, which can seriously affect physical, psychological, and sexual health.
Sheng Deng +10 more
doaj +1 more source
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study
BJU International, 2023 To examine the global disease burden and country‐specific trends of penile cancer incidence by age group and investigate its associations with several factors.
Junjie Huang +12 more
semanticscholar +1 more source
Penile sparing therapy for penile cancer [PDF]
Translational Andrology and Urology, 2020 Penile cancer is a rare malignancy with a reported incidence of 0.66-1.44 per 100,000 men, and a reported mortality of 0.15-0.37 per 10,000 men. Expert clinical examination and histological diagnosis from biopsy is required to determine the extent and invasion of disease, which is paramount in planning of appropriate treatment.
Shomik Sengupta +2 more
openaire +3 more sources
Journal of Cancer Research and Clinical Oncology, 2023 Penile cancer is a rare malignancy with a poor prognosis, even with various treatment options. Considering the little progress in the study of the pathogenesis and treatment of penile cancer because of the lack of models that mimic the biological ...
Yuanqiao He +7 more
semanticscholar +1 more source
Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs. [PDF]
PLoS ONE, 2013 The incidence of penile cancer varies between populations but is rare in developed nations. Penile cancer is associated with a number of established risk factors and associated diseases including phimosis with chronic inflammation, human papillomavirus ...
Marilia Freitas Calmon +17 more
doaj +1 more source
A Review of Penile Cancer [PDF]
Advances in Urology, 2009 Cancer of the penis is a rare tumour in Europe and mainly affects the elderly patient population. The aim of this paper was to analyse and study the characteristics of this tumour, in our patient population.Materials and Methods.A retrospective study was conducted on penile tumours diagnosed and treated in the Urology Department of the Hospital ...
A. Tabernero Gomez +5 more
openaire +3 more sources